Introduction
Converging evidence suggests that stimulatory drugs of abuse, including alcohol, act through mechanisms involving the brain neurotransmitter dopamine (DA), and the neural systems which it innervates, with the nucleus accumbens as the key mesolimbic zone for mediating these effects. [1] [2] [3] Alcohol dose dependently stimulates the release of DA in the nucleus accumbens, 4 and withdrawal from alcohol has been shown to be associated with reduced levels of dopamine in this same region. 5 The amygdala is another dopamine-rich brain region which has close connections with the nucleus accumbens and recently has received increasing interest in the context of alcohol and other drug abuse. [6] [7] [8] Alcoholism characterized by late-onset, social dependency and anxiety (ie, type 1) has been suggested to be associated with an underlying dopaminergic deficit. This is in contrast to the observed serotonergic deficit in early-onset type 2 alcoholism, which is characterized by novelty seeking, impulsive behavior and social hostility. 9 Preliminary results from positron emission tomographic (PET) and single photon emission tomographic (SPET) studies have indicated alterations in either dopamine transporter (DAT) densities or presynaptic DA function in the striatum of type 1 alcoholics [10] [11] [12] and in unclassified (type 1 vs type 2) alcoholics, 13 although contradictory results have also been reported in a study of unclassified alcoholics. 14 Other articles have reported low DA D 2 receptor densities in the striatum of unclassified alcoholics [14] [15] [16] and endocrinological measurements have shown decreased DA mediated activity among unclassified alcoholics. [17] [18] [19] [20] [21] The radioligand [ 125 I]epidepride ((S)-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-iodo-2,3, dimethoxybenzamine) has a very high affinity for DA D 2 receptors, with very low non-specific binding, and has been widely used to label DA D 2 receptors in the human brain. 22, 23 It also binds to DA D 3 [24] [25] [26] and has been previously used for imaging DAT both in vitro and in vivo. [24] [25] [26] [27] It has 30-and Ͼ60-fold selectivities in vitro over serotonin and noradrenalin transporters, respectively, 25, 26 which makes it far superior to older cocaine derivatives like ␤-CIT, frequently used in previous in vivo studies. Such radioligands in human post-mortem whole hemispheric autoradiography provide high resolution images from different brain levels, to compare with in vivo studies (ie, PET and SPET) and enable a more detailed study of various structures. 23, [27] [28] [29] [30] Because of the relatively low spatial resolution of in vivo imaging methods, it has been difficult to differentiate nucleus accumbens from the dorsal striatum, and earlier results have indicated changes in the nigrostriatal system (ie, substantia nigra, nucleus caudatus, putamen, globus pallidus), which has been implied in the control of movement and may not be as important as the mesolimbic system in the context of addiction. 10, [12] [13] [14] [15] Aside from our preliminary results, regarding DAT in the nucleus accumbens of seven type 1 alcoholics and healthy controls, 30 there are no other reports on DA D 2 /D 3 receptor and DAT densities in the nucleus accumbens or amygdala of human alcoholics. The aim of this study was to compare the DA D 2 /D 3 receptor and transporter densities in the nucleus accumbens and amygdala in alcoholics classified as type 1 or 2, according to Cloninger, 9 and healthy controls. Whole hemispheric autoradiography was used in the present study to evaluate DA binding sites in both the nucleus accumbens and amygdala from the same sections. Only type 1 alcoholics had significantly lower numbers of pre-and post-synaptic DA receptor binding sites in these limbic areas, which supports Cloninger's neurogenetic model of alcoholic subtypes, where type 1 alcoholism is associated with a dopaminergic deficit, and type 2 is not.
Materials and methods

Brain sampling
Human brains used were obtained for clinical necropsy by the Department of Forensic Medicine, University of Oulu, Finland, and this portion of the study was approved by the Ethics Committee of the University of Oulu and the National Institute of Medicolegal Affairs, Helsinki, Finland. The brains were removed, cleaned of the dura, and divided at the midsagittal plane. The left hemisphere was placed with the midsagittal plane on a glass-plate before freezing (−75°C). Medical records on the cause of death, previous diseases and medical treatments were collected. A postmortem analysis for drugs, including alcohol, and the normal necropsy protocol were also performed. Gross neuropathological evaluation for the right hemisphere was performed during necropsy, and a more detailed neuroanatomical evaluation was made on the left hemisphere sections used in the study from an adjacent Nissl stained section. None of the study hemispheres exhibited damage or neuroanatomical abnormalities.
Diagnostics
Diagnoses were made by two physicians, independently of each other. Mental disorders were coded according to DSM-III-R diagnostic criteria and alcoholics were subclassified as type 1 or type 2 according to Cloninger. 9 The kappa coefficient of diagnostic agreement was 0.9; ie, one type 2 alcoholic included in the study was diagnosed as a type 1 alcoholic by the second diagnostician. 31 Otherwise diagnoses were unanimous. Alcoholics were selected after alcohol dependence or harmful use was evident, based on autopsy results, medical records and anamnestic data. The most important criteria for defining the two groups of alcoholics were early onset (before the age of 25) of alcohol abuse and documented, severe antisocial behavior among type 2 alcoholics. Controls were selected when autopsy or anamnestic data revealed no indications of harmful substance misuse. Subjects having psychotic disorders or any diseases (such as epilepsy), or using medication that affected the central nervous system (such as neuroleptics or antidepressants), were excluded.
Study subjects
All 27 cases were white Caucasians. The study groups consisted of nine type-1 alcoholics in the [
125 I]epidepride binding study (seven males, two females; mean age 52.7 years; post-mortem delay 11.9 ± 4.5 h; mean ± SD), eight type 1 alcoholics in the [
125 I]PE2I binding study (seven males, one female; mean age 52.9 years; post mortem delay 12.0 ± 4.8 h; mean ± SD), and eight type 2 alcoholics (males; mean age 34.6 years; post mortem delay 14.1 ± 3.4 h; mean ± SD) and 10 controls who were free of psychiatric diagnosis in both the [ 125 I]epidepride and [
125 I]PE2I study (eight males, two females; mean age 53.5 years; post-mortem delay 14.8 ± 9.2 h; mean ± SD). From one female type 1 alcoholic only DA D 2 /D 3 -receptors were measured, due to methodological limitations. Eight of the nine type 1 alcoholics had alcohol in their blood at the time of death, and one alcoholic (included in both ligand binding studies) had an abstinence period of 10 h. One of the controls had a small amount of alcohol in his blood at the time of death (0.036%). Two of the type 1 alcoholics had traces of diazepam in their blood samples. All type 2 alcoholics had alcohol in their blood at the time of death, three had traces of benzodiazepines and one was positive for cannabinoids. All subjects died of sudden causes. Nine controls died because of myocardial infarction and one due to aorta dissecation. The causes of death in the type 1 alcoholic group were pneumonia (2), lethal ethanol intoxication (2), myocardial infarction (2), suicide by hanging (1) and subdural hematoma on the right side (1) . The causes of death in the type 2 alcoholic group were suicide by hanging (3), knife wound (2), gunshot wound (1), rupture of heart due to a car accident (1) and cardiac death (1).
Cryosectioning
The object glasses (size 100 × 220 × 1.0-1.2 mm) were washed in a laboratory dishwasher, dipped in ethanol for 15 min, dried and then dipped briefly in gelatine. 29 The glass plates were then dried overnight at room temperature under a cover to protect against dust. For cryosectioning, the glass plate was removed from the frozen hemisphere, which was then put into a specially designed rubber box with a specimen holder, with the midsagittal plane of the hemisphere facing up. 29 A semi-liquid gel (approximate concentration 5 g l −1 , 5°C) of carboxymethylcellulose (CMC) was added while carefully checking the horizontal level of the midsagittal surface. The positioning of the hemisphere to obtain parallel sections to the bicommisural line of Talairach was achieved by adjusting the hemisphere parallel to a ruler over the upper margin of the anterior and lower margin of the posterior commissura and the surface of the cryostat specimen holder (the cutting plane). Once the hemisphere-specimen holder-CMC block was totally frozen, the rubber box was removed.
Serial sectioning of the block was performed by a heavy-duty cryomicrotome (LKB 2250, LKB, Stockholm, Sweden), and the temperature of the hemisphere-CMC block was allowed to obtain a cutting temperature (−15°C optimal) before cryosectioning. The brain was sectioned into 100-m horizontal (cantomeatal) sections. A thin tissue paper was put on each section, after which a transparent tape (3M, type 810, St Paul, MN, USA) was fastened to the block by gentle rubbing. Tissue sections cut with the cryotome adhered to the tissue paper, and were transferred to the gelatinized glass plates using a soft paintbrush. The tape and paper were carefully removed, with the sections thawed onto the glass plates. The sections were allowed to air dry before they were stored with dehydrating agents at −25°C until use. The nucleus accumbens was defined as starting at the level where the caput nucleus caudatus and putamen unite, and sectioned through (from dorsal to ventral). The median accumbens sections located 2-4 mm ventrally from the uppermost edge of the amygdala were chosen for the study (see Figure 1 in Ref 27 for a frontal view). Because this region of interest's area was small, we decided to measure the visible structure as a whole without trying to distinguish separate nuclei. The amygdala could not be matched with the median accumbens' levels in one type 1 alcoholic and in one control. RBI, Natick, MA, USA. The study protocols were based on affinity constants and receptor occupancies from former autoradiographic and ligand binding studies with these same ligands, 23, 27 and the study concentrations for both ligands were chosen based on their K d values. Incubation time to reach equilibrium was chosen to be 1 h according to earlier studies with these same ligands. 22, 23, 26, 27 The first series of sections (eight controls, seven type 1 alcoholics, six type 2 alcoholics) were incubated in a solution (volume 2.5 l) containing approximately 24 pM of [ 125 I]epidepride (the incubation concentration) in Tris-HCl buffer, pH 7.4, 0.05 M, containing 0.1% (weight/volume) ascorbic acid, 120 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , and 1 mM MgCl 2 . (+)-Butaclamol (15 M) was used as a specific displacer to determine nonspecific binding. Washing was performed in cold buffer for 3 × 10 min, followed by a brief cold wash by dipping the sections into distilled water. The sections were dried for 10 min with a gentle stream of warm air 14, [32] [33] [34] [35] [36] age was also included as a covariant in univariate ANCOVA, followed by Bonferroni's test for multiple comparisons. A P-value less than 0.05 was considered significant. The Kappa coefficent of agreement was calculated with regard to the matching of diagnoses between two diagnosticians, 31 where a value over 0.75 is considered excellent. the nucleus accumbens and amygdala (data not shown). [ 125 I]PE2I bound with high intensity in the nucleus accumbens, indicating a high DAT density in this structure (Figure 2) . No specific binding was detected in the amygdala. [ 125 I]PE2I binding in the nucleus accumbens was completely (Ͼ95%) displaced by ␤-CIT (2 M), a DAT inhibitor and cocaine derivative (data not shown). [ 125 I]PE2I slightly accumulated in the white matter of both cerebrum and cerebellum (Figure 2) , possibly due to its relatively high lipophilicity, 27 and the addition of ␤-CIT did not affect this accumulation. This non-specific binding accounted for approximately 30% of the specific binding in the nucleus accumbens, and no differences were found between the groups in this regard (data not shown).
Autoradiography
The mean binding of [ ; mean ± SD; P = 0.007) when compared with the control group (6.33 ± 0.39 fmol mg −1 ) (Figure 3 ) and 41.0% lower in the amygdala in the type 1 alcoholic group (0.23 ± 0.14 fmol mg −1 ; mean ± SD; P = 0.029) when compared with the control group (0.39 ± 0.10 fmol ), but none of these results reached statistical significance (Figures 3-5) .
Binding to the pre-synaptic (DAT) and post-synaptic (DA D 2 /D 3 receptor) sites had a tendency towards positive correlation in the type 1 alcoholics (r = 0.53, P = 0.18) and in the control group (r = 0.50, P = 0.14), but in the type 2 alcoholics the tendency was negative (r = − 0.47, P = 0.24). Results from autoradiography with [ 125 I]epidepride binding to DA D 2 receptors on the striatal level will be reported separately.
Discussion
We observed marked reductions in both DAT alcohol preferring animals, and no reports have found changes in K d . Therefore, we chose ligand concentration to be close to K d , in order to optimize binding dynamics. By increasing the concentration to eg two or three times, the K d value would have resulted in much higher non-specific binding, which could have disturbed the detection of differences between the groups. Furthermore, considering the aforementioned reports, we still had reasonable basis to assume that possible differences in binding would reflect the difference in binding site density (B max ) and not in the binding affinity (K d ).
Our results are consistent with previous reports from in vivo studies on striatal DAT, 10,12-13 although one PET study 14 did not find a reduction in the DAT of unclassified alcoholics. However, only five alcoholics were evaluated in that study, which might explain the negative result. In previous PET studies, 14, 15 variations in striatal DA D 2 receptor densities had no substantial correlation with the period of alcohol abstinence, suggesting some independence of this parameter from withdrawal. Regarding DAT, a previous study 13 found considerably lower densities in the striatum of alcoholics after admission for detoxification, where DAT densities returned to levels of healthy controls after a 4-week abstinence. In the aforementioned study, about one half of the alcoholics had a history of criminal offences (P Laine, Dept of Psychiatry, University of Oulu, personal communication), which is indicative of type 2 alcoholism. One previous SPET study found Molecular Psychiatry normal DAT densities among type 2 alcoholics 10 after a minimum abstinent period of 2 months, while type 1 alcoholics had considerably lower densities, as observed in our study. These results suggest some pathological difference between type 1 and type 2 alcoholics, which is reflected by the stark difference between the receptor binding profiles in the present study as well, where alcoholic subjects were intoxicated at the time of death.
Human genetic studies imply that the DA D 2 receptor gene allele A1 is associated with alcoholism. [41] [42] However, there have now been numerous studies specifically addressing the issue of an association between alleles at DRD2 and alcoholism, which have been divided into those supporting the association [41] [42] and those maintaining the contrary view. [43] [44] [45] [46] PET and functional studies have indicated some evidence to suggest that decreased DAT and DA D 2 receptor densities in type 1 alcoholics are not merely a consequence of recent alcohol abuse but, at least to some extent, a trait marker for alcoholism. 12, 19 Thus, our findings may reflect some genetic or developmental variability that is related to addiction vulnerability. Further studies are needed to clarify the extent of this apparent deficit in DA receptor densities in alcoholics, and if they are more related to variations in neurodevelopment or chronic alcohol exposure, and to what extent these variables apply to DA D 2 /D 3 receptors and DAT.
A decrease in DA D 2 /D 3 receptors should, in effect, result in an attenuation of DA activity. Endocrinological measurements, in response to DA agonists, have also been performed in unclassified alcoholics as a means of assessing brain tuberoinfundibular DA function. The growth hormone response to the DA agonist apomorphine is decreased in abstinent alcoholics, 17, 18 and those alcoholics showing a persistent, attenuated response to apomorphine are more vulnerable to relapse, 20, 21 which supports an association between low levels of DA neurotransmission and addiction potential. There is also evidence to suggest that a reduced DA D 2 receptor function in alcohol-dependent men is not only a state marker of residual heavy drinking, but also a more permanent trait marker. 12, 19 In conclusion, our results support Cloninger's neurogenetic model of alcoholic subtypes, which suggests that type 1 alcoholism is associated with a dopaminergic deficit, while type 2 is not. Additionally these data suggest that type 1 alcoholics could benefit from drugs that enhance dopaminergic function, perhaps in an analogous way to what was recently demonstrated in an animal study using DA D 3 partial agonists to treat cocaine craving and reduce vulnerability to relapse. 47 In human type 1 alcoholics such drugs could help to restore sub-optimal levels of dopaminergic activity by reducing both the craving for alcohol in abstinence and the euphoria subsequent to alcohol's release of dopamine in the nucleus accumbens, thus providing a negative reinforcement for relapse. This may not be the case among type 2 alcoholics however, and alcoholic patients must be classified before such treatment strategies are applied.
